AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-81012249/gensia-sicor-gets-tentative.html" title="Facts and information about Gensia Sicor Gets Tentative ANDA Approval For Pamidronate Disodium For Injection.(Gensia Sicor Pharmaceuticals Inc. receives abbreviated new drug application for pamidronate disodium for the treatment of Paget disease)">Gensia Sicor Gets Tentative ANDA Approval For Pamidronate Disodium For Injection.(Gensia Sicor Pharmaceuticals Inc. receives abbreviated new drug application for pamidronate disodium for the treatment of Paget disease)</a>
Close
Set up an RSS feed that alerts you when new articles from Women's Health Weekly are available.
Frequently asked questions about RSS feeds
Gensia Sicor Gets Tentative ANDA Approval For Pamidronate Disodium For Injection.(Gensia Sicor Pharmaceuticals Inc. receives abbreviated new drug application for pamidronate disodium for the treatment of Paget disease)
2001 DEC 27 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has tentatively approved an Abbreviated New Drug Application (ANDA), filed by Gensia Sicor Pharmaceuticals, Inc., for pamidronate disodium for injection.
The active drug substance is manufactured and supplied by Sicor, Inc.'s wholly owned subsidiary, Sicor S.p.A. Pamidronate is used in the treatment of moderate or severe hypercalcemia associated with malignancy and moderate to severe Paget disease.
Based on data from IMS Health, a market research firm, U.S. sales of pamidronate in 2001 ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- SICOR Announces Tentative ANDA Approval for Pamidronate Disodium Injection.
- Press release article from: PR Newswire March 1, 2002 700+ words
...Application (ANDA) by its wholly owned subsidiary, Gensia Sicor Pharmaceuticals, Inc. for pamidronate disodium injection. This approval follows SICOR's tentative approval for pamidronate disodium for injection received in November 2001. The...
- SICOR Announces Tentative ANDA Approval for Pamidronate Disodium for Injection.
- Press release article from: PR Newswire November 29, 2001 700+ words
...approved an Abbreviated New Drug Application (ANDA), filed by its wholly owned subsidiary, Gensia Sicor Pharmaceuticals, Inc. for pamidronate disodium for injection. The active drug substance is manufactured and supplied by SICOR's wholly...
- SICOR Announces Final ANDA Approval for Pamidronate Disodium Injection.
- Press release article from: PR Newswire March 28, 2002 700+ words
...Inc. today announced that its wholly owned subsidiary, Gensia Sicor Pharmaceuticals, Inc., has received final approval of...ANDA) from the Food and Drug Administration (FDA) for pamidronate disodium injection. Under this agreement, SICOR will manage the...
- Gensia Sicor Announces Collaboration With Sankyo in Diabetes Research
- Press release article from: PR Newswire April 21, 1997 700+ words
...DIEGO, April 21 /PRNewswire/ -- Gensia Sicor Inc. (Nasdaq: GNSA) today announced...insulin dependent (Type II) diabetes. Gensia Sicor's diabetes research focuses on a class...cell and regulate the target enzyme. Gensia Sicor believes that these compounds represent...
- Gensia Sicor Announces Private Placement of Units; Sale of Land in San Diego
- Press release article from: PR Newswire January 2, 1998 700+ words
...Jan. 2 /PRNewswire/ -- Gensia Sicor Inc. (Nasdaq: GNSA) today...investors including two members of Gensia Sicor's senior management as well...E. Panoz, chairman of the Gensia Sicor Board of Directors and interim...
- Gensia Sicor Announces Planned Relocation of Corporate Offices
- Press release article from: PR Newswire September 2, 1997 700+ words
...DIEGO, Sept. 2 /PRNewswire/ -- Gensia Sicor Inc. (Nasdaq: GNSA) today announced...efficiencies and reduce operating costs. Gensia Sicor's wholly-owned subsidiary, Gensia...products. During the last two years, Gensia Sicor has invested in significant upgrades...
- Gensia Sicor Announces Marketing Agreement With Abbott Laboratories.
- Press release article from: PR Newswire January 29, 1999 700+ words
...Jan. 29 /PRNewswire/ -- Gensia Sicor Inc. (Nasdaq: GNSA) today...its wholly owned subsidiary, Gensia Sicor Pharmaceuticals, Inc., has...marketing and distribution of Gensia Sicor's growing portfolio of oncology...
- Gensia Sicor Announces ANDA Approval for Propofol Injectable Emulsion 1%.
- Press release article from: PR Newswire January 5, 1999 700+ words
...Jan. 5 /PRNewswire/ -- Gensia Sicor Inc. (Nasdaq: GNSA) today...its wholly owned subsidiary, Gensia Sicor Pharmaceuticals, Inc., has...marketed by Zeneca Inc. Once Gensia Sicor's propofol formulation is launched...
Source: HighBeam Research, Gensia Sicor Gets Tentative ANDA Approval For Pamidronate Disodium...